Freemont Management S.A. Reduces Stock Position in Astera Labs, Inc. $ALAB

Freemont Management S.A. trimmed its position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) by 9.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 101,600 shares of the company’s stock after selling 10,300 shares during the quarter. Astera Labs makes up 1.7% of Freemont Management S.A.’s portfolio, making the stock its 18th biggest holding. Freemont Management S.A.’s holdings in Astera Labs were worth $11,135,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Royal Bank of Canada lifted its stake in Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after buying an additional 95,409 shares in the last quarter. AQR Capital Management LLC increased its position in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares in the last quarter. Empowered Funds LLC increased its position in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares in the last quarter. First Trust Advisors LP raised its holdings in shares of Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. raised its holdings in shares of Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after acquiring an additional 1,977 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Down 5.0%

ALAB stock opened at $303.62 on Friday. The stock has a 50-day moving average price of $349.32 and a two-hundred day moving average price of $220.59. The company has a market cap of $52.04 billion, a PE ratio of 205.15, a price-to-earnings-growth ratio of 3.42 and a beta of 3.66. Astera Labs, Inc. has a 12-month low of $96.79 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.88 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently commented on ALAB. Rothschild & Co Redburn started coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Susquehanna upped their target price on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Needham & Company LLC raised their price target on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $275.75.

View Our Latest Stock Report on Astera Labs

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 139,951 shares of the stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $200.16, for a total value of $28,012,592.16. Following the completion of the transaction, the chief executive officer owned 3,929,183 shares of the company’s stock, valued at approximately $786,465,269.28. This represents a 3.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,700,432 shares of company stock valued at $449,062,723 in the last ninety days. Insiders own 10.40% of the company’s stock.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.